genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Sepsis Study Reveals Four Subtypes, Suggests Why Some Trials Miss Mark
News
Alzheimer’s “Seeding-Prone” Beta Amyloid Structure Determined
News
Coffee Consumption Alters Microbiome and Improves Gut Motility
News
Citing “Strong Sales,” Pension Manager Buys Partial Keytruda Rights for $1.3B
News
Smart Insulin for Diabetes Therapy Could Protect against Hypoglycemia
Insights
Artificial Intelligence
Hey Google. Is This Lung Cancer?
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
Tech Exclusives
Rising to the Challenge of Intensifying Bioprocesses
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
May 2019 Vol. 39 No. 5
Genomics’ “Green” Future
A-Lists
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
A-Lists
Top 10 Under 40 of 2019
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Insights
Top 10 Sequencing Companies
May 2019 Vol. 39 No. 5
Top 10 Immuno-Oncology Collaborations
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Artificial Intelligence
Hey Google. Is This Lung Cancer?
News
Sepsis Study Reveals Four Subtypes, Suggests Why Some Trials Miss Mark
News
Coffee Consumption Alters Microbiome and Improves Gut Motility
News
Citing “Strong Sales,” Pension Manager Buys Partial Keytruda Rights for $1.3B
Magazine
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
May 2019 Vol. 39 No. 5
Genomics’ “Green” Future
May 2019 Vol. 39 No. 5
Crafting a More Efficient CAR T-Cell Industry
May 2019 Vol. 39 No. 5
All About That Base Editing
May 2019 Vol. 39 No. 5
Signs, Portents, and Immuno-Oncology Biomarkers
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Podcasts
GENcast: Explore, Learn, and Collaborate on Viral Safety in Biomanufacturing
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
Upcoming Webinars
Recent Advances and the Future of Antibody Engineering
Videos
3D Bioprinted Organ Just Took Its First “Breath”
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Companies
Sanofi
Sanofi
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Sanofi
FDA Approves Sanofi’s Dengue Prevention Vaccine Dengvaxia in Narrower Patient Population
Sanofi
Sanofi to Develop Biomunex Bi-, Multi-Specific Antibodies for Immuno-Oncology and Other Areas
Sanofi
To Treat Acute Cannabinoid Overdose, Opiant Looks to Reformulation of Drinabant
Sanofi
Opiant Pharmaceuticals to Develop Sanofi’s Acute Cannabinoid Overdose Candidate Drinabant
Sanofi
Sanofi, Denali Launch $1B+ Alliance to Develop RIPK1 Inhibitors for Neurological, Inflammatory Diseases
Sanofi
Sanofi, Evotec Launch New “BRIDGE” Partnership to Accelerate Drug Discovery
Sanofi
Regulus Axing 60% of Workforce, Pauses Patient Recruitment for Lead Program
Sanofi
Sanofi Agrees to Transfer Infectious Disease Unit, 100 Employees to Evotec
Sanofi
Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership
Sanofi
NYC, NY State Promote Cluster-Building with $1B+ in Incentives, New Startup...
Sanofi
Sanofi to Build $431M Vaccine Plant in Toronto
Sanofi
Oxford BioMedica, Bioverativ to Develop Lentiviral Vectors for Hemophilia Gene Therapy
Sanofi
Sanofi to Acquire Ablynx for $4.8B
Sanofi
Sanofi Snaps Up Bioverativ for $11.6B, Boosting Hemophilia and Rare Disease...
Sanofi
Sanofi Plans Approval Filings for Cancer, Immunology Candidates
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Sanofi’s global vaccines unit Sanofi Pasteur has launched an up-to-$805 million partnership with Translate Bio to develop messenger RNA vaccines for up to five undisclosed infectious disease pathogens. [Ryan Jeffs/Wikicommons]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar14_2017_WikiCommons_MicroRNAAndmRNAVisualization2173942127-324x160.jpg "Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership")
